Yaky Yanay
2016
In 2016, Yaky Yanay earned a total compensation of $436.5K as Co, CEO and President at Pluristem Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Salary | $245,312 |
|---|---|
| Stock Awards | $169,500 |
| Other | $21,721 |
| Total | $436,533 |
Yanay received $245.3K in salary, accounting for 56% of the total pay in 2016.
Yanay also received $169.5K in stock awards and $21.7K in other compensation.
Rankings
In 2016, Yaky Yanay's compensation ranked 11,644th out of 14,075 executives tracked by ExecPay. In other words, Yanay earned more than 17.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,644 out of 14,075 | 17th |
Division Manufacturing | 4,541 out of 5,489 | 17th |
Major group Chemicals And Allied Products | 1,621 out of 1,895 | 15th |
Industry group Drugs | 1,311 out of 1,538 | 15th |
Industry Biological Products, Except Diagnostic Substances | 234 out of 279 | 16th |
Source: SEC filing on April 3, 2018.
Yanay's colleagues
We found one more compensation record of an executive who worked with Yaky Yanay at Pluristem Therapeutics in 2016.
2016
Zami Aberman
Pluristem Therapeutics
Chief Executive Officer
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019